My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 93

    1.

    Why differentiate low molecular weight heparins for venous thromboembolism?

    Fareed J, Walenga JM.

    Thromb J. 2007 Jun 19;5:8. No abstract available. PMID: 17578577 [PubMed]Related articlesFree article

    2.

    Are all low molecular weight heparins equivalent in the management of venous thromboembolism?

    Fareed J, Jeske W, Fareed D, Clark M, Wahi R, Adiguzel C, Hoppensteadt D.

    Clin Appl Thromb Hemost. 2008 Oct;14(4):385-92. Review.PMID: 18815137 [PubMed - indexed for MEDLINE]Related articles

    3.

    Low-molecular-weight heparin for thromboprophylaxis.

    Camporese G, Bernardi E.

    Curr Opin Pulm Med. 2009 Sep;15(5):443-54. Review.PMID: 19593139 [PubMed - indexed for MEDLINE]Related articles

    4.

    Economic assessments of low molecular weight heparin in venous thromboembolism.

    Ward A, Getsios D, O'Brien J, Caro JJ.

    Expert Rev Pharmacoecon Outcomes Res. 2004 Feb;4(1):39-47.PMID: 19807334 [PubMed - in process]Related articles

    5.

    Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review.

    Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Schünemann HJ.

    J Exp Clin Cancer Res. 2008 Jul 18;27:21. Review.PMID: 18634550 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prevention of venous thromboembolism after ischemic stroke.

    Kase CS, Pineo GF.

    Curr Opin Pulm Med. 2008 Sep;14(5):389-96. Review.PMID: 18664967 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.

    Prandoni P.

    Thromb J. 2008 Sep 9;6:13.PMID: 18782432 [PubMed - in process]Related articlesFree article

    8.

    The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.

    Kiphuth IC, Köhrmann M, Huttner HB, Schellinger PD.

    Expert Opin Drug Saf. 2009 Sep;8(5):585-97. Review.PMID: 19614560 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients.

    Seruya M, Venturi ML, Iorio ML, Davison SP.

    Plast Reconstr Surg. 2008 Dec;122(6):1701-8.PMID: 19050522 [PubMed - indexed for MEDLINE]Related articles

    10.

    Recommendations on biosimilar low-molecular-weight heparins.

    Harenberg J, Kakkar A, Bergqvist D, Barrowcliffe T, Casu B, Fareed J, Mismetti P, Ofosu FA, Raake W, Samama M, Schulman S; Subcommittee on Control of Anticoagulation of the SSC of the ISTH.

    J Thromb Haemost. 2009 Jul;7(7):1222-5. Epub 2009 Mar 23.PMID: 19323788 [PubMed - indexed for MEDLINE]Related articles

    11.

    Management of venous thromboembolism in patients with cancer.

    Noble S, Jenkins DA.

    Br J Hosp Med (Lond). 2009 Jul;70(7):380-5.PMID: 19584778 [PubMed - indexed for MEDLINE]Related articles

    12.

    Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.

    Duhl AJ.

    J Reprod Med. 2008 Sep;53(9):657-66.PMID: 18839817 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Suitability of the use of low-molecular-weight heparins in the prevention of venous thromboembolism]

    Garrido Martínez MT, Aguayo Canela M, Herrera Carranza J, Chaparro Moreno I, Ynfante Ferrus M, de la Rosa Báez JA, Fernández Lisón LC.

    Farm Hosp. 2008 Sep-Oct;32(5):261-73. Spanish. PMID: 19150041 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Determination of anti-Xa levels in pregnant women treated with low molecular weight heparins for prevention of recurrent venous thromboembolism: a case report and review of the literature.

    Kinori M, Saar N, Justo D, Almog R.

    Thromb Res. 2008;122(2):289-90; author reply 291. Epub 2008 Feb 21. No abstract available. PMID: 18178242 [PubMed - indexed for MEDLINE]Related articles

    15.

    Venous thromboembolism prophylaxis for the medical patient: where do we stand?

    Yavin Y, Cohen AT.

    Semin Respir Crit Care Med. 2008 Feb;29(1):75-82. Review.PMID: 18302089 [PubMed - indexed for MEDLINE]Related articles

    16.

    Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient.

    Dinwoodey DL, Ansell JE.

    Cardiol Clin. 2008 May;26(2):145-55, v. Review.PMID: 18406991 [PubMed - indexed for MEDLINE]Related articles

    17.

    Low molecular weight heparins as antineoplastic agents.

    Siragusa S.

    Recent Pat Anticancer Drug Discov. 2008 Nov;3(3):159-61. Review.PMID: 18991784 [PubMed - indexed for MEDLINE]Related articles

    18.

    The use of low-molecular-weight heparins in pregnancy--how safe are they?

    Deruelle P, Coulon C.

    Curr Opin Obstet Gynecol. 2007 Dec;19(6):573-7. Review.PMID: 18007136 [PubMed - indexed for MEDLINE]Related articles

    19.

    Controversial issues in thromboprophylaxis with low-molecular weight heparins in palliative care.

    Tassinari D, Santelmo C, Scarpi E, Tombesi P, Sartori S.

    J Pain Symptom Manage. 2008 Aug;36(2):e3-4. No abstract available. PMID: 18655952 [PubMed - indexed for MEDLINE]Related articles

    20.

    Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.

    ten Cate-Hoek AJ, Prins MH.

    Thromb Res. 2008;122(5):584-98. Epub 2007 Nov 8. Review.PMID: 17996281 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk